Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shangrao Shengkai Biotechnology is a Chinese life sciences company that specializes in the research, development, and production of high-quality biological reagents and raw materials. Based in the Shangrao Economic and Technological Development Zone, the company focuses on providing essential components for the In Vitro Diagnostics (IVD) industry, including recombinant antigens and monoclonal antibodies. Their product portfolio supports a wide range of applications, such as infectious disease testing, cardiac marker detection, and inflammation monitoring. The company serves as a critical supplier for diagnostic kit manufacturers and research institutions globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shangrao Shengkai Biotechnology.